Search - tctmd.com

Displaying 461 - 480 of 662

Sort: Relevancy | Date

Presentation TCT 2013

Complex Congenital Heart Disease Intervention: Year in Review

Presenter: Frank Ing

October 31, 2013

Presentation TCT 2013

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Presenter: Ted Feldman

October 30, 2013

Presentation TCT 2013

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

Presenter: Paul Grayburn

October 30, 2013

Presentation TCT 2013

For Left Atrial Appendage Occlusion

Presenter: Brian Whisenant

October 30, 2013

News Conference News TCT 2013

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

October 30, 2013

Presentation TCT 2013

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Presenter: Brian Whisenant

October 30, 2013

Presentation TCT 2013

Safety and Early Efficacy of the Lariat Procedure: Results from the U.S. Transcatheter LAA Ligation Consortium

Presenter: Matthew J. Price

October 29, 2013

Presentation TCT 2013

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Presenter: Miroslava Stolcova

October 29, 2013

Presentation TCT 2013

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

Presenter: Saibal Kar

October 29, 2013

Presentation TCT 2013

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Presenter: Vivek Y. Reddy

October 29, 2013

Presentation TCT 2013

Structural Intervention: LAA Closure, HOCM, Paravalvular Leak

Presenter: Anita Asgar

October 28, 2013

Presentation TCT 2013

Pro(2)

Presenter: Vivek Reddy

October 28, 2013

Presentation TCT 2013

Next Generation Devices for Left Atrial Appendage Occlusion

Presenter: Horst Sievert

October 28, 2013

Presentation TCT 2013

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Presenter: Juan Granada

October 28, 2013

Presentation TCT 2013

Didactic(4)

Presenter: Jessica Forman

October 28, 2013

Presentation TCT 2013

Con(2)

Presenter: Darryl Wells

October 28, 2013

Presentation TCT 2013

Case Presentation: LAA Exclusion in a Patient With Atrial Fibrillation

Presenter: Evgeny Merkulov

October 28, 2013

Presentation TCT 2013

Case #3: LAA Closure With a Novel Device

Presenter: Wolfgang Bocksch

October 28, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Presenter: Gerald Werner

October 28, 2013

Presentation TCT 2013

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Presenter: Saibal Kar

October 28, 2013

Advertisement

Complex Congenital Heart Disease Intervention: Year in Review

The Common Dilemma of Managing Operator Learning Curve Issues and Evolving Clinical Trial Considerations (eg, Control Populations, Clinical Indications, and Optimal Endpoints)

Practical and Meaningful Clinical Trial Pathways for New Mitral Valve Therapies

For Left Atrial Appendage Occlusion

Debate Leaves Little Doubt of LAA Closure Efficacy in the Prevention of Stroke in AF Patients

Clinical Trial Alternatives for New LAA Occlusion Devices: For High-Risk AF Patients Who Are Tolerant to Anticoagulation or Poor Anticoagulation Candidates Due to Bleeding Risks...

Safety and Early Efficacy of the Lariat Procedure: Results from the U.S. Transcatheter LAA Ligation Consortium

Long term follow up of 134 patients with non valvular atrial fibrillation and contraindications to oral anticoagulation therapy, treated with the Ampatzer Cardiac Plug Device for LAA

Long Term Efficacy of Left Atrial Appendage Closure with WATCHMAN® Device

A Cost Benefit Analysis of Left Atrial Appendage Closure Versus Warfarin for Stroke Prevention in Atrial Fibrillation

Structural Intervention: LAA Closure, HOCM, Paravalvular Leak

Pro(2)

Next Generation Devices for Left Atrial Appendage Occlusion

Editorial Comment: LAA Exclusion: Anatomical Considerations, Device Selection and Outcomes

Didactic(4)

Con(2)

Case Presentation: LAA Exclusion in a Patient With Atrial Fibrillation

Case #3: LAA Closure With a Novel Device

Are Novel LAA Closure Devices (Beyond Watchman) Needed in Germany?

Are Novel LAA Closure Devices (Beyond Watchman) Needed in the USA?

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content